Magnetic and Plasmonic Contrast Agents in Optical Coherence Tomography.
Amy L OldenburgRichard L BlackmonJustin M SierchioPublished in: IEEE journal of selected topics in quantum electronics : a publication of the IEEE Lasers and Electro-optics Society (2016)
Optical coherence tomography (OCT) has gained widespread application for many biomedical applications, yet the traditional array of contrast agents used in incoherent imaging modalities do not provide contrast in OCT. Owing to the high biocompatibility of iron oxides and noble metals, magnetic and plasmonic nanoparticles, respectively, have been developed as OCT contrast agents to enable a range of biological and pre-clinical studies. Here we provide a review of these developments within the past decade, including an overview of the physical contrast mechanisms and classes of OCT system hardware addons needed for magnetic and plasmonic nanoparticle contrast. A comparison of the wide variety of nanoparticle systems is also presented, where the figures of merit depend strongly upon the choice of biological application.
Keyphrases
- optical coherence tomography
- magnetic resonance
- diabetic retinopathy
- contrast enhanced
- optic nerve
- molecularly imprinted
- high resolution
- magnetic resonance imaging
- single molecule
- diffusion weighted
- physical activity
- high throughput
- mass spectrometry
- risk assessment
- quantum dots
- energy transfer
- human health
- health risk
- fluorescence imaging